Skip to main content
. 2025 Jul 28;21(11):4908–4926. doi: 10.7150/ijbs.116639

Figure 2.

Figure 2

Knockdown of LINC02802 inhibits lung cancer cell proliferation and migration. (A-B) qPCR analysis confirming LINC02802 knockdown efficiency in lung cancer cell lines. (C-D) CCK-8 assays assessing the effect of LINC02802 knockdown on cell proliferation. (E-F) Colony formation assays evaluating the impact of LINC02802 knockdown on clonogenic potential. (G) Wound healing assay assessing the effects of LINC02802 knockdown on migration and invasion. (H-J) LINC02802 knockdown reduces tumor formation in xenograft mouse models. Representative images of tumors (H), tumor volumes (I), and tumor weights (J) are shown. (n = 5 mice per group). Data are presented as mean ± SD (bar plots). *P < 0.05; **P < 0.01; ***P < 0.001; ns not significant.